SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Myocardial InfarctionDiabetes Mellitus, Type 2
Interventions
DRUG

SGLT2 inhibitor

Patients started on SGLT2 inhibitors after PCI for AMI

Trial Locations (1)

Unknown

RECRUITING

Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Uijeongbu St. Mary Hospital

OTHER

collaborator

Incheon St.Mary's Hospital

OTHER

collaborator

Daejeon St. Mary's hospital

OTHER

collaborator

Bucheon St. Mary's Hospital

OTHER

collaborator

St Vincent's Hospital

OTHER

collaborator

Yeouido St. Mary's Hospital

OTHER

collaborator

Sejong General Hospital

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

Andong Hospital

UNKNOWN

collaborator

Chungnam National University Hospital

OTHER

collaborator

St. Carollo General Hospital

UNKNOWN

collaborator

Pusan National University Yangsan Hospital

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Jeju National University Hospital

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Inje University

OTHER

lead

Kiyuk Chang

OTHER